Characterization and Scale-Up of Cyanogen Bromide Chemical Activation of Sepharose CL-4B in a Stirred Tank Reactor to Purify the rHBsAg
Abstract
The aim of this paper was to characterize and to scale-up the CNBr chemical activation of Sepharose CL-4B in a stirred tank reactor to purify the recombinant Hepatitis B surface antigen for use in vaccines. The activation quality was assessed measuring the concentration of the cyanate esters and the percentage of nitrogen in the activated matrix. The Sepharose CL-4B incorporated less than 50% of the initial CNBr amount added to the matrix, but the monoclonal antibody CB.Hep-1, used as immunoligand to purify the rHBsAg, was efficiently immobilized in a weakly activated matrix (<8 μmol/mL of matrix). The impellent type has a significant influence on activated matrix quality. The constant power per volume unit was a proper criterion to scale-up the Sepharose CL-4B March's modified chemical activation procedure with CNBr.Recommended Citation
Fernández, Eutimio G.; Montero, José A.; Valdés, Rodolfo; Arce, Milagros G.; Tamayo, Andrés B.; Geada, Déborah; Medina, Yenisley; Benitez, Malvina; Guevara, Yarysel; Ferro, William; López, Jorge L.; La O, Maylin; Aldama, Yuirisleyi; Padilla, Sigifredo A.; and Figueroa, Alejandro
(2008)
"Characterization and Scale-Up of Cyanogen Bromide Chemical Activation of Sepharose CL-4B in a Stirred Tank Reactor to Purify the rHBsAg,"
International Journal of Chemical Reactor Engineering:
Vol. 6:
A33.
Available at: http://www.bepress.com/ijcre/vol6/A33
